As demand for COVID-19 vaccines collapses in many areas of the U.S., states are scrambling to use stockpiles of doses before they expire and have to be added to the millions that have already gone to waste.
The vaccines authorized in the U.S., made by Pfizer, Moderna and Johnson & Johnson, can last for up to about six monthsA senior HHS official familiar with vaccine distribution plans took issue with the word “wastage,” saying it implies mismanagement when states are effectively overseeing their inventories. The CDC, however, uses the term “wastage” on its website and asks states to report their numbers.
The CDC said Thursday that the federal government, jurisdictions and vaccine providers have a strong partnership to get as many people vaccinated as possible while reducing vaccine wastage, and that the likelihood of leaving unused doses in a vial may increase as demand slows, even when providers continue to follow best practices to use every dose possible.
The fading demand comes as the pandemic itself wanes in the U.S. On Thursday, the CDC said about 90% of the U.S. population lives in counties where the risk of coronavirus is posing a low or medium threat — meaning residents don’t need to wear masks in most indoor settings. That was up
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Three more Covid-related deaths and 483 hospital casesThe total number of deaths linked to the virus reported by Stormont's Department of Health is 3,220.
Read more »
Group of physicians combats misinformation as unproven COVID-19 treatments continue to be prescribedA group of doctors is calling on state medical boards to take disciplinary action against doctors spreading dangerous misinformation about the treatment of COVID-19.
Read more »
AAA: Traveler confidence rebounding in 2022 as COVID-19 cases dropBased on the responses, AAA cites the boost in travel confidence is due to the COVID-19 vaccine, among other factors.
Read more »
EXPLAINER: Why Pfizer needs time to make COVID-19 treatmentPfizer’s new COVID-19 treatment came with a catch when it debuted late last year: Supplies were limited, and it can take months to make the tablets. Company leaders say they are expanding production and expect big gains in the next several months.
Read more »